(Q45098928)

9 December 2017

title

Decreased 5-hydroxymethylcytosine levels are associated with TET2 mutation and unfavorable overall survival in myelodysplastic syndromes (English)

1 reference

9 December 2017

Xiaoliu Liu

1

1 reference

9 December 2017

Guangsen Zhang

2

1 reference

9 December 2017

Yan Yi

3

1 reference

9 December 2017

Le Xiao

4

1 reference

9 December 2017

Minfei Pei

5

1 reference

9 December 2017

Sufang Liu

6

1 reference

9 December 2017

Yunya Luo

7

1 reference

9 December 2017

Haiying Zhong

8

1 reference

9 December 2017

Yunxiao Xu

9

1 reference

9 December 2017

Wenli Zheng

10

1 reference

9 December 2017

Jiankai Shen

11

1 reference

9 December 2017

publication date

27 March 2013

1 reference

9 December 2017

1 reference

9 December 2017

volume

54

1 reference

9 December 2017

issue

11

1 reference

9 December 2017

page(s)

2466-2473

1 reference

Recurrent DNMT3A mutations in patients with myelodysplastic syndromes

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778408

Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778408

Recurrent IDH mutations in high-risk myelodysplastic syndrome or acute myeloid leukemia with isolated del(5q).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778408

Mutation in TET2 in myeloid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778408

Acquired mutations in TET2 are common in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778408

Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778408

MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778408

Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778408

Revised international prognostic scoring system for myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778408

Nomenclature for the description of human sequence variations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778408

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778408

TET genes: new players in DNA demethylation and important determinants for stemness

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778408

Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778408

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778408

IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778408

Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778408

21 January 2018

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778408

Cancer epigenetics: modifications, screening, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778408

DNA methylation: past, present and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778408

DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778408

The DNA methyltransferases of mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778408

Expression levels of DNA methyltransferase genes do not correlate with p15INK4B gene methylation in myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778408

Myelodysplastic Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778408

10.3109/10428194.2013.778408

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference